[Breast cancer metastatic to a renal cell carcinoma]. 2004

L K Van Wynsberge, and P Vierling, and A Lampel
Klinik für Urologie und Kinderurologie der Stadt Villingen-Schwenningen. lodewijkvw@mac.com

BACKGROUND Renal tumors are often diagnosed during routine radiological-imaging. A newly diagnosed renal tumor next to an existing cancer is challenging since a primary or a secondary renal neoplasm has to be considered in the differential diagnosis. METHODS A 64-year-old woman underwent radical mastectomy and axillary lymphadenectomy for cancer of the right breast. After surgery, the patient underwent chemotherapy and radiotherapy because of multiple metastases. Six years later, computed tomography (CT) obtained as follow-up examination revealed a solid mass in the left kidney. Because radiological differentiation between metastatic breast cancer and primary kidney tumor was impossible and fine needle biopsy of renal tumors should be avoided, a nephrectomy was performed. Histologic diagnosis was a metastatic breast cancer within a primary renal cell carcinoma. Whereas the primary tumor was receptor negative, the breast cancer metastasis was estrogen receptor positive. CONCLUSIONS In a renal mass of unknown nature in patients in good general condition and acceptable life-expectancy, surgical exploration with partial or radical nephrectomy is justified in spite of a synchronous metastatic tumor of different origin. This is the only way to obtain a definitive histologic diagnosis. A primary renal tumor can be treated curatively, preventing secondary complications, such as hematuria. In this case, the changed receptor state of the breast cancer metastasis also offered the patient the possibility of new palliative chemotherapy and hormonal manipulation.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

L K Van Wynsberge, and P Vierling, and A Lampel
April 2006, Surgery,
L K Van Wynsberge, and P Vierling, and A Lampel
January 2005, The breast journal,
L K Van Wynsberge, and P Vierling, and A Lampel
August 2009, Singapore medical journal,
L K Van Wynsberge, and P Vierling, and A Lampel
May 1992, Postgraduate medicine,
L K Van Wynsberge, and P Vierling, and A Lampel
January 2008, Pathology, research and practice,
L K Van Wynsberge, and P Vierling, and A Lampel
January 2020, Cancer drug resistance (Alhambra, Calif.),
L K Van Wynsberge, and P Vierling, and A Lampel
October 1979, The Journal of urology,
L K Van Wynsberge, and P Vierling, and A Lampel
February 2012, Clinical advances in hematology & oncology : H&O,
L K Van Wynsberge, and P Vierling, and A Lampel
August 2001, American journal of surgery,
L K Van Wynsberge, and P Vierling, and A Lampel
April 1982, Urology,
Copied contents to your clipboard!